A 67-year-old male with known metastatic carcinoid to the liver diagnosed 3 years earlier treated with somatostatin and hepatic artery embolization started developing dyspnoea and obstructive cardiac symptoms, and workup was suggestive of cardiac carcinoid. Transoesophageal echocardiogram (TEE) revealed a 6 × 4 cm subpulmonic mass within the free wall of the right ventricle (RV) encroaching on the RV outflow tract (RVOT) without any valvular involvement (Panel D). Cardiac magnetic resonance (CMR) showed a mass centred in the epicardial fat and RV free wall extending towards the RVOT region (Panels A-C). External beam radiation therapy was given without reduction in the size of the mass; in addition, the patient developed episodes of ventricular tachycardia (VT), so he was referred for surgical excision. After median sternotomy, and cardiopulmonary bypass, the tumour was visible on the free wall of the RV without extension through the endocardial surface. It was possible to separate the tumour with sharp dissection and circumferentially resect it (Panels H and I) followed by patch repair of the right ventriculotomy site. Surgical pathology revealed synaptophysin and chromogranin positivity (Panels F and G) confirming the diagnosis of metastatic carcinoid. Postoperative TEE showed no evidence of residual tumour. At follow-up 3 months later, the patient cardiac symptoms improved and no further episodes of VT were recorded. The case is unique because of the myocardial involvement by metastatic carcinoid disease causing RVOT obstruction in the absence of the usual valvular or endocardial affection.
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